Open AccessVenetoclax and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome: Bursa Uludag University Experience
Author(s) -
İbrahim Ethem Pınar,
Fahir Özkalemkaş,
Vildan Özkocaman,
Tuba Ersal,
Cumali Yalçin,
Bedrettin Orhan,
Ömer Candar
Publication year - 2021
Publication title -
turkish journal of internal medicine (online)
Language(s) - English
Resource type - Journals
ISSN - 2687-4245
DOI - 10.46310/tjim.877068
Subject(s) - azacitidine , venetoclax , medicine , myeloid leukemia , refractory (planetary science) , hematology , complete remission , oncology , leukemia , gastroenterology , chemotherapy , chronic lymphocytic leukemia , gene expression , astrobiology , dna methylation , gene , biochemistry , chemistry , physics